AlloVir (ALVR) News Today → Obama’s Forever Term [exposed] (From Porter & Company) (Ad) Free ALVR Stock Alerts $0.75 0.00 (0.00%) (As of 05/16/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 16 at 7:51 AM | marketbeat.comQ2 2024 EPS Estimates for AlloVir, Inc. (NASDAQ:ALVR) Cut by AnalystAlloVir, Inc. (NASDAQ:ALVR - Free Report) - Analysts at Leerink Partnrs dropped their Q2 2024 EPS estimates for AlloVir in a report issued on Monday, May 13th. Leerink Partnrs analyst M. Foroohar now forecasts that the company will post earnings per share of ($0.04) for the quarter, down from theMay 16 at 2:58 AM | americanbankingnews.comAlloVir (NASDAQ:ALVR) Trading Down 2.9%May 14 at 10:14 AM | investorplace.comALVR Stock Earnings: AlloVir Misses EPS for Q1 2024May 1, 2024 | finance.yahoo.comAlloVir, Inc. (ALVR)April 2, 2024 | marketbeat.comShort Interest in AlloVir, Inc. (NASDAQ:ALVR) Rises By 5.7%AlloVir, Inc. (NASDAQ:ALVR - Get Free Report) was the recipient of a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 6,270,000 shares, a growth of 5.7% from the February 29th total of 5,930,000 shares. Based on an average trading volume of 1,970,000 shares, the short-interest ratio is currently 3.2 days.March 21, 2024 | stockhouse.comDEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AlloVirMarch 19, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AlloVir, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALVRMarch 19, 2024 | stockhouse.comINVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AlloVirMarch 18, 2024 | investorplace.comALVR Stock Earnings: AlloVir Misses EPS for Q4 2023March 18, 2024 | marketbeat.comAlloVir, Inc. (NASDAQ:ALVR) Short Interest UpdateAlloVir, Inc. (NASDAQ:ALVR - Get Free Report) was the recipient of a large growth in short interest in the month of February. As of February 29th, there was short interest totalling 5,930,000 shares, a growth of 7.4% from the February 14th total of 5,520,000 shares. Based on an average daily volume of 2,050,000 shares, the short-interest ratio is currently 2.9 days.March 17, 2024 | businesswire.comALVR DEADLINE TUESDAY: ROSEN, A LEADING LAW FIRM, Encourages AlloVir, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities ...March 17, 2024 | businesswire.comALVR DEADLINE TUESDAY: ROSEN, A LEADING LAW FIRM, Encourages AlloVir, Inc. Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – ALVRMarch 15, 2024 | stockhouse.com4-DAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the FirmMarch 15, 2024 | prnewswire.comALVR LAWSUIT ALERT: Levi & Korsinsky Notifies AlloVir, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineMarch 14, 2024 | prnewswire.comClass Action Filed Against AlloVir, Inc. (ALVR) Seeking Recovery for Investors - Contact The Gross Law FirmMarch 14, 2024 | stockhouse.com5-DAY DEADLINE ALERT: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the FirmMarch 12, 2024 | prnewswire.comALVR IMPORTANT DEADLINE: ROSEN, GLOBAL INVESTOR COUNSEL, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important March 19 Deadline in Securities Class Action - ALVRMarch 12, 2024 | prnewswire.comAlloVir, Inc. Sued for Securities Law Violations - Contact Levi & Korsinsky Before March 19, 2024 to Discuss Your Rights - ALVRMarch 11, 2024 | markets.businessinsider.comDEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AlloVirMarch 11, 2024 | marketbeat.comAlloVir, Inc. (NASDAQ:ALVR) Receives Average Rating of "Reduce" from AnalystsAlloVir, Inc. (NASDAQ:ALVR - Get Free Report) has been given an average rating of "Reduce" by the six brokerages that are currently covering the firm, MarketBeat reports. Two investment analysts have rated the stock with a sell recommendation, three have given a hold recommendation and one has assMarch 9, 2024 | markets.businessinsider.comSHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of AlloVirMarch 8, 2024 | markets.businessinsider.comALLOVIR INVESTOR ALERT: Kirby McInerney LLP Alerts AlloVir, Inc. (ALVR) Investors of Upcoming Lead Plaintiff Deadline in Class Action LawsuitMarch 7, 2024 | prnewswire.comThe Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of March 19, 2024 in AlloVir, Inc. Lawsuit - ALVRMarch 6, 2024 | prnewswire.comLost Money on AlloVir, Inc.(ALVR)? Join Class Action Suit Seeking Recovery - Contact Levi & KorsinskyMarch 5, 2024 | prnewswire.comROSEN, A LEADING LAW FIRM, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALVRMarch 3, 2024 | marketbeat.comAlloVir (ALVR) Scheduled to Post Quarterly Earnings on MondayAlloVir (NASDAQ:ALVR) will be releasing earnings on Monday, March 4, Yahoo Finance reports.March 3, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AlloVir, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALVRFebruary 29, 2024 | msn.comSHAREHOLDER ALERT: Potential Recovery for AlloVir, Inc. (ALVR) InvestorsFebruary 27, 2024 | stockhouse.comSHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the FirmFebruary 27, 2024 | prnewswire.comShareholders that lost money on AlloVir, Inc.(ALVR) should contact Levi & Korsinsky about pending Class Action - ALVRFebruary 25, 2024 | prnewswire.comROSEN, NATIONAL TRIAL LAWYERS, Encourages AlloVir, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - ALVRFebruary 23, 2024 | prnewswire.comLevi & Korsinsky Notifies Shareholders of AlloVir, Inc.(ALVR) of a Class Action Lawsuit and an Upcoming DeadlineFebruary 22, 2024 | markets.businessinsider.comAlloVir Investor Deadline ApproachingFebruary 22, 2024 | finance.yahoo.comIs AlloVir (NASDAQ:ALVR) In A Good Position To Deliver On Growth Plans?February 22, 2024 | prnewswire.comClass Action Filed Against AlloVir, Inc. (ALVR) Seeking Recovery for Investors - Contact The Gross Law FirmFebruary 21, 2024 | prnewswire.comALLOVIR SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In AlloVir To Contact Him Directly To Discuss Their OptionsFebruary 21, 2024 | markets.businessinsider.comShareholders that lost money on AlloVir, Inc. (ALVR) should contact Levi & Korsinsky about pending Class Action - ALVRFebruary 20, 2024 | markets.businessinsider.comAlloVir Ongoing Deadline AlertFebruary 20, 2024 | prnewswire.comClass Action Filed Against AlloVir, Inc. (ALVR) Seeking Recovery for Investors - Contact Levi & KorsinskyFebruary 17, 2024 | markets.businessinsider.comLost Money on AlloVir, Inc.(ALVR)? Join Class Action Suit Seeking Recovery - Contact Levi & KorsinskyFebruary 16, 2024 | prnewswire.comROSEN, SKILLED INVESTOR COUNSEL, Encourages AlloVir, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ALVRFebruary 16, 2024 | prnewswire.comALLOVIR SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $25,000 In AlloVir To Contact Him Directly To Discuss Their OptionsFebruary 16, 2024 | prnewswire.comLevi & Korsinsky Reminds AlloVir Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 19, 2024 - ALVRFebruary 15, 2024 | stockhouse.comSHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the FirmFebruary 15, 2024 | markets.businessinsider.comShareholders that lost money on AlloVir, Inc.(ALVR) should contact Levi & Korsinsky about pending Class Action - ALVRFebruary 15, 2024 | prnewswire.comSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in AlloVir, Inc. of Class Action Lawsuit and Upcoming Deadlines - ALVRFebruary 15, 2024 | marketbeat.comAlloVir, Inc. (NASDAQ:ALVR) Receives Consensus Rating of "Reduce" from BrokeragesAlloVir, Inc. (NASDAQ:ALVR - Get Free Report) has received a consensus recommendation of "Reduce" from the six research firms that are presently covering the firm, Marketbeat Ratings reports. Two analysts have rated the stock with a sell rating, three have given a hold rating and one has issued aFebruary 14, 2024 | stockhouse.comINVESTOR ACTION NOTICE: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the FirmFebruary 13, 2024 | stockhouse.comINVESTOR ACTION REMINDER: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the FirmFebruary 12, 2024 | stockhouse.comINVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in AlloVir, Inc. with Losses of $100,000 to Contact the Firm Get AlloVir News Delivered to You Automatically Sign up to receive the latest news and ratings for ALVR and its competitors with MarketBeat's FREE daily newsletter. Email Address Biden replacement revealed? (Ad)A former CIA insider just announced a disturbing prediction… Biden will withdraw as the Democrat nominee on June 13. See his shocking evidence in this new report ALVR Media Mentions By Week ALVR Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ALVR News Sentiment▼0.070.55▲Average Medical News Sentiment ALVR News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ALVR Articles This Week▼62▲ALVR Articles Average Week Get AlloVir News Delivered to You Automatically Sign up to receive the latest news and ratings for ALVR and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CVM News CRIS News PASG News PLX News ATHA News CGTX News OTLK News GRTS News DTIL News TIL News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ALVR) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersGold Set to EXPLODE!Gold Safe ExchangeWhy Is Gold On a MASSIVE rally? Huge AlertsThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingHow Biden has already won 2024Porter & CompanyCharles Payne Demystifies OptionsUnstoppable ProsperityBiden FINISHED On June 13th?Paradigm PressBiden Nomination CANCELED?The Freeport Society Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding AlloVir, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
